A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
Current Pharmaceutical Analysis · 2026-10 · 22 (8) · 746-758
DOI: 10.1016/j.cpan.2026.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2026-10. Verfasst von Manoj V. Mahale und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mahale, M. V., & Kachave, R. N. (2026). A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations. Current Pharmaceutical Analysis, 22(8), 746-758. https://doi.org/10.1016/j.cpan.2026.09.002
Vancouver
Mahale MV, Kachave RN. A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations. Current Pharmaceutical Analysis. 2026;22(8):746-758. doi:10.1016/j.cpan.2026.09.002
BibTeX
@article{Mahale2026,
author = {Mahale, Manoj V. and Kachave, Ramanlal N.},
title = {A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations},
journal = {Current Pharmaceutical Analysis},
year = {2026},
volume = {22},
number = {8},
pages = {746--758},
doi = {10.1016/j.cpan.2026.09.002}
}
EUVIMED